The Immune System of the Brain

NeuroImmune Biology

Volumn 7, Issue C, 2007, Pages 127-144

  Bucky Jones, T ^a   Lucin, Kurt M ^b,c,d   Popovich, Phillip G ^a,b,c,d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Immunology and Medical Genetics

^c The Integrated Biomedical Science Graduate Program

^d Center for Brain and Spinal Cord Repair

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957026947     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)00207-4     Document Type: Review

References (196)

1. Medawar P.B. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. British J Pathol 29 (1948) 58-69
2. Reese T.S., and Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34 (1967) 207-217
3. Risau W., and Wolburg H. Development of the blood-brain barrier. Trends Neurosci 13 5 (1990) 174-178
4. Hart D.N., and Fabre J.W. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med 8-1- 154 2 (1981) 347-361
5. Lassmann H., Zimprich F., Vass K., and Hickey W.F. Microglial cells are a component of the perivascular glia. J Neurosci Res 28 (1991) 236-243
6. Streit W.J., Graeber M.B., and Kreutzberg G.W. Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol 105 (1989) 115-126
7. Wekerle H., Linington C., Lassmann H., and Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci 9 (1986) 271-277
8. Hickey W.F., Hsu B.L., and Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 28 (1991) 254-260
9. Graeber M.B., Streit W.J., Büringer D., Sparks D.L., and Kreutzberg G.W. Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain. J Neuropathol Exp Neurol 51 3 (1992) 303-311
10. Sedgwick J.D., Schwender S., Gregersen R., Dorries R., and ter Meulen V. Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive. J Exp Med 177 4 (1993) 1145-1152
11. Jander S., and Stoll G. Strain-specific expression of microglial keratan sulfate proteoglycans in the normal rat central nervous system: inverse correlation with constitutive expression of major histocompatibility complex class II antigens. Glia 18 3 (1996) 255-260
12. Hickey W.F., and Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239 (1988) 290-292
13. Bradbury M.W., Cserr H.F., and Westrop R.J. Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am J Physiol 240 (1981) F329-F336
14. Hochwald G.M., Van Driel A., Robinson M.E., and Thorbecke G.J. Immune response in draining lymph nodes and spleen after intraventricular injection of antigen. Int J Neurosci 39 3-4 (1988) 299-306
15. Bradbury M.W.B., and Cole D.F. The role of the lymphatic system in drainage of cerebrospinal fluid and aqueous humor. J Physiol London 299 (1980) 353-365
16. Kida S., Pantazis A., and Weller R.O. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol 19 (1993) 480-488
17. Streilein J.W. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 5 3 (1993) 428-432
18. Streilein J.W. Unraveling immune privilege. Science 270 (1995) 1158-1159
19. Carson M.J., and Sutcliffe J.G. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 1-1- 55 1 (1999) 1-8
20. Sun D., Coleclough C., and Whitaker J.N. Nonactivated astrocytes downregulate T cell receptor expression and reduce antigen-specific proliferation and cytokine production of myelin basic protein (MBP)-reactive T cells. J Neuroimmunol 78 1-2 (1997) 69-78
21. Gold R., Schmied M., Tontsch U., Hartung H.P., Wekerle H., Toyka K.V., et al. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo. Brain 119 Pt 2 (1996) 651-659
22. Carson M.J., Sutcliffe J.G., and Campbell I.L. Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J Neurosci Res 55 1 (1-1-1999) 127-134
23. Weber G.F., Abromson-Leeman S., and Cantor H. A signaling pathway coupled to T cell receptor ligation by MMTV superantigen leading to transient activation and programmed cell death. Immunity 2 4 (1995) 363-372
24. Ford A.L., Foulcher E., Lemckert F.A., and Sedgwick J.D. Microglia induce CD4T lymphocyte final effector function and death. J Exp Med 184 5 (11-1-1996) 1737-1745
25. Wilbanks G.A., and Streilein J.W. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol 22 (1992) 1031-1036
26. Xiao B.G., Bai X.F., Zhang G.X., Hojeberg B., and Link H. Shift from anti- to proinflammatory cytokine profiles in microglia through LPS- or IFN-gamma-mediated pathways. Neuroreport 7 12 (8-12-1996) 1893-1898
27. Fabry Z., Topham D.J., Fee D., Herlein J., Carlino J.A., Hart M.N., et al. TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol 155 1 (1995) 325-332
28. Taylor A.W., and Streilein J.W. Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid. Neuroimmunomodulation 3 2-3 (1996) 112-118
29. Carrieri P.B., Provitera V., Bruno R., Perrella M., Tartaglia G., Busto A., et al. Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis. Neurol Res 19 6 (1997) 599-600
30. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., and Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J Exp Med 189 6 (3-15-1999) 1005-1010
31. Bechmann I., Mor G., Nilsen J., Eliza M., Nitsch R., and Naftolin F. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 27 1 (1999) 62-74
32. Frigerio S., Silei V., Ciusani E., Massa G., Lauro G.M., and Salmaggi A. Modulation of fas-ligand (Fas-L) on human microglial cells: an in vitro study. J Neuroimmunol 105 2 (2000) 109-114
33. Flugel A., Schwaiger F.W., Neumann H., Medana I., Willem M., Wekerle H., et al. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol 10 3 (2000) 353-364
34. Neumann H. Control of glial immune function by neurons. Glia 36 2 (2001) 191-199
35. Neumann H., Boucraut J., Hahnel C., Misgeld T., and Wekerle H. Neuronal control of MHC Class II inducibility in rat astrocytes and microglia. Eur J Neurosci 8 (1996) 2582-2590
36. Regoli D., Boudon A., and Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46 4 (1994) 551-599
37. McGillis J.P., Humphreys S., and Reid S. Characterization of functional calcitonin gene-related peptide receptors on rat lymphocytes. J Immunol 147 10 (1991) 3482-3489
38. Santambrogio L., Lipartiti M., Bruni A., and Dal Toso R. Dopamine receptors on human T- and B-lymphocytes. J Neuroimmunol 45 1-2 (1993) 113-119
39. Aune T.M., McGrath K.M., Sarr T., Bombara M.P., and Kelley K.A. Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol 151 3 (1993) 1175-1183
40. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 4 (2000) 595-638
41. Lee S.C., Collins M., Vanguri P., and Shin M.L. Glutamate differentially inhibits the expression of Class II MHC antigens on astrocytes and microglia. J Immunol 148 11 (1992) 3391-3397
42. Frohman E.M., Vayuvegula B., Gupta S., and van den N.S. Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms. Proc Natl Acad Sci USA 85 4 (1988) 1292-1296
43. Neumann H., and Wekerle H. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol 57 1 (1998) 1-9
44. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 5497 (2000) 1768-1771
45. Deckert M., Sedgwick J.D., Fischer E., and Schluter D. Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction. Acta Neuropathol (Berl) 111 6 (2006) 548-558
46. Davis S.J., Ikemizu S., Wild M.K., and van der Merwe P.A. CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol Rev 163 (1998) 217-236
47. Borriello F., Tizard R., Rue E., and Reeves R. Characterization and localization of Mox2, the gene encoding the murine homolog of the rat MRC OX-2 membrane glycoprotein. Mamm Genome 9 2 (1998) 114-118
48. Aldskogius H., and Kozlova E.N. Central neuron-glial and glial-glial interactions following axon injury. Prog Neurobiol 55 1 (1998) 1-26
49. Darlington C.L. Astrocytes as targets for neuroprotective drugs. Curr Opin Investig Drugs 6 7 (2005) 700-703
50. Bush T.G., Puvanachandra N., Horner C.H., Polito A., Ostenfeld T., Svendsen C.N., et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23 2 (1999) 297-308
51. Okada S., Nakamura M., Katoh H., Miyao T., Shimazaki T., Ishii K., et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12 7 (2006) 829-834
52. Fontana A., Kristensen F., Dubs R., Gemsa D., and Weber E. Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol 129 6 (1982) 2413-2419
53. Eddleston M., and Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54 1 (1993) 15-36
54. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 2 (2001) 180-190
55. Chung I.Y., and Benveniste E.N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 144 (1990) 2999-3007
56. Raivich G., Bohatschek M., Kloss C., Werner A., Jones L.L., and Kreutzberg G.W. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 30 (1999) 77-105
57. Kreutzberg G.W. Microglia: A sensor for pathological events in the CNS. Trends in Neurosciences 19 8 (1996) 312-318
58. Giulian D., and Lachman L.B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228 (1985) 497-499
59. Giulian D., and Baker T.J. Peptides released by ameboid microglia regulate astroglial proliferation. J Cell Biol 101 (1985) 2411-2415
60. Giulian D., and Ingeman J.E. Colony-stimulating factors as promoters of ameboid microglia. J Neurosci 8 (1988) 4707-4717
61. Sawada M., Suzumura A., and Yamamoto H. Activation and proliferation of the isolated microglia by colony stimulating factor-1 and possible involvement of protein kinase C. Brain Res 509 (1990) 119-124
62. Plant S.R., Arnett H.A., and Ting J.P. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination. GLIA 49 1 (1-1-2005) 1-14
63. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8 6 (2005) 752-758
64. Rabchevsky A.G., and Streit W.J. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J Neurosci Res 47 1 (1997) 34-48
65. Giulian D., Baker T.J., Shih L.N., and Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 164 (1986) 594-604
66. Smith G.M., and Hale J.H. Macrophage/Microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J Neurosci 17 24 (12-15-1997) 9624-9633
67. Fontana A., Fierz W., and Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307 (1984) 273-276
68. Wong G.H., Bartlett P.F., Clark-Lewis I., Battye F., and Schrader J.W. Inducible expression of H-2 and Ia antigens on brain cells. Nature 8-23- 310 5979 (1984) 688-691
69. DuBois J.H., Hammond-Tooke G.D., and Cuzner M.L. Expression of major histocompatibility complex antigens in neonate rat primary mixed glial cultures. J Neuroimmunol 9 6 (1985) 363-377
70. Horwitz M.S., Evans C.F., Klier F.G., and Oldstone M.B. Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules. Lab Invest 79 2 (1999) 235-242
71. Zeinstra E., Wilczak N., Streefland C D., and Keyser J. Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 1-17- 11 1 (2000) 89-91
72. Bo L., Mork S., Kong P.A., Nyland H., Pardo C.A., and Trapp B.D. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 51 2 (1994) 135-146
73. Panek R.B., Lee Y.J., Itoh-Lindstrom Y., Ting J.P., and Benveniste E.N. Characterization of astrocyte nuclear proteins involved in IFN-gamma- and TNF-alpha-mediated class II MHC gene expression. J Immunol 153 10 (11-15-1994) 4555-4564
74. Dong Y., Rohn W.M., and Benveniste E.N. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes. J Immunol 162 8 (4-15-1999) 4731-4739
75. Nikcevich K.M., Gordon K.B., Tan L., Hurst S.D., Kroepfl J.F., Gardinier M., et al. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol 158 2 (1-15-1997) 614-621
76. Satoh J., Lee Y.B., and Kim S.U. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res 704 1 (12-15-1995) 92-96
77. Soos J.M., Ashley T.A., Morrow J., Patarroyo J.C., Szente B.E., and Zamvil S.S. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production. Int Immunol 11 7 (1999) 1169-1179
78. Cross A.H., and Ku G. Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis. J Neuroimmunol 110 1-2 (10-2-2000) 76-82
79. Mueller D.L., Jenkins M.K., and Schwartz R.H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7 (1989) 445-480
80. Sedgwick J.D., Mossner R., Schwender S t., and Meulen V. Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system. J Exp Med 173 5 (1991) 1235-1246
81. Weber F., MeinL E., Aloisi F., Nevinny-Stickel C., Albert E., Wekerle H., et al. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Brain 117 Pt 1 (1994) 59-69
82. Matsumoto Y., Ohmori K., and Fujiwara M. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76 2 (1992) 209-216
83. Banati R.B., and Graeber M.B. Surveillance, intervention and cytotoxicity: is there a protective role of microglia. Dev Neurosci 16 3-4 (1994) 114-127
84. Lawson L.J., Perry V.H., Dri P., and Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 1 (1990) 151-170
85. Ling E.A., and Wong W.C. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7 (1993) 9-18
86. Nimmerjahn A., Kirchhoff F., and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 5726 (2005) 1314-1318
87. Ranson P.A., and Thomas W.E. Pinocytosis as a select marker of ramified microglia in vivo and in vitro. J Histochem Cytochem 39 (1991) 853-858
88. Streit W.J., Walter S.A., and Pennell N.A. Reactive microgliosis. Prog Neurobiol 57 6 (1999) 563-581
89. Gehrmann J., Banati R.B., and Kreutzberg G.W. Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules. J Neuroimmunol 48 2 (1993) 189-198
90. Elkabes S., DiCicco-Bloom E.M., and Black I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 16 8 (1996) 2508-2521
91. Nakajima K., Kikuchi Y., Ikoma E., Honda S., Ishikawa M., Liu Y., et al. Neurotrophins regulate the function of cultured microglia. Glia 24 (1998) 272-289
92. Maeda A., and Sobel R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 55 3 (1996) 300-309
93. Moffett J.R., Els T., Espey M.G., Walter S.A., Streit W.J., and Namboodiri M.A. Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes. Exp Neurol 144 2 (1997) 287-301
94. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19 12 (1999) 5054-5065
95. Possel H., Noack H., Putzke J., Wolf G., and Sies H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 32 1 (2000) 51-59
96. Banati R.B., Gehrmann J., Schubert P., and Kreutzberg G.W. Cytotoxicity of microglia. Glia 7 (1993) 111-118
97. Heyes M.P. The kynurenine pathway and neurologic disease. Therapeutic strategies. Adv Exp Med Biol 398 (1996) 125-129
98. Benveniste E.N. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 9 3-4 (1998) 259-275
99. Vass K., and Lassmann H. Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 137 4 (1990) 789-800
100. Andersson P.B., Perry V.H., and Gordon S. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 176 1 (1992) 255-259
101. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., and Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20 16 (2000) 6309-6316
102. Stern E.L., Quan N., Proescholdt M.G., and Herkenham M. Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide [In Process Citation]. J Neuroimmunol 109 2 (2000) 245-260
103. Streit W.J., and Kreutzberg G.W. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268 2 (1988) 248-263
104. Shuman S.L., Bresnahan J.C., and Beattie M.S. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 50 5 (1997) 798-808
105. Zajicek J.P., Wing M., Scolding N.J., and Compston D.A. Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 115 Pt 6 (1992) 1611-1631
106. Gregersen R., Lambertsen K., and Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20 1 (2000) 53-65
107. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2 7 (1996) 788-794
108. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4 1 (1998) 78-83
109. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., and Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4 11 (2001) 1116-1122
110. Li W.W., Setzu A., Zhao C., and Franklin R.J. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158 1-2 (2005) 58-66
111. Lodge P.A., and Sriram S. Regulation of microglial activation by TGF-b, IL-10, and CSF-1. J Leukoc Biol 60 (1996) 502-508
112. Tan J., Town T., Saxe M., Paris D., Wu Y., and Mullan M. Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Immunol 163 12 (1999) 6614-6621
113. Novikova L.N., Novikov L.N., and Kellerth J.O. Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur J Neurosci 12 2 (2000) 776-780
114. McTigue D.M., Horner P.J., Stokes B.T., and Gage F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18 14 (1998) 5354-5365
115. De Simone R., Giampaolo A., Giometto B., Gallo P., Levi G., Peschle C., et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 54 2 (1995) 175-187
116. Issazadeh S., Navikas V., Schaub M., Sayegh M., and Khoury S. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol 161 3 (8-1-1998) 1104-1112
117. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., and Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17 (1987) 1271-1278
118. Aloisi F., Ria F., Penna G., and Adorini L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160 10 (1998) 4671-4680
119. Cash E., and Rott O. Microglial cells qualify as the stimulators of unprimed CD4+ and CD8+ T lymphocytes in the central nervous system. Clin Exp Immunol 98 2 (1994) 313-318
120. Sedgwick J.D., Ford A.L., Foulcher E., and Airriess R. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. J Immunol 160 (1998) 5320-5330
121. Magnus T., Chan A., Grauer O., Toyka K.V., and Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol 167 9 (2001) 5004-5010
122. Chan A., Hummel V., Weilbach F.X., Kieseier B.C., and Gold R. Phagocytosis of apoptotic inflammatory cells downregulates microglial chemoattractive function and migration of encephalitogenic T cells. J Neurosci Res 84 6 (2006) 1217-1224
123. Williams K., Ulvestad E., and Antel J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol 24 12 (1994) 3031-3037
124. Bechmann I., Kwidzinski E., Kovac A.D., Simburger E., Horvath T., Gimsa U., et al. Turnover of rat brain perivascular cells. Exp Neurol 168 2 (2001) 242-249
125. Allan S.M., Allan S.M., and Rothwell N.J. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2 10 (2001) 734-744
126. Minami M., Katayama T., and Satoh M. Brain cytokines and chemokines: roles in ischemic injury and pain. J Pharmacol Sci 100 5 (2006) 461-470
127. Biber K., de Jong E.K., van Weering H.R., and Boddeke H.W. Chemokines and their receptors in central nervous system disease. Curr Drug Targets 7 1 (2006) 29-46
128. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19 8 (1999) 819-834
129. Ransohoff R.M., and Tani M. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?. Trends Neurosci 21 4 (1998) 154-159
130. Asensio V.C., and Campbell I.L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 22 11 (1999) 504-512
131. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., and Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152 1 (1998) 74-87
132. Owens T., Wekerle H., and Antel J. Genetic models for CNS inflammation. Nat Med 7 2 (2001) 161-166
133. Wang X., Yue T.L., Barone F.C., White R.F., Gagnon R.C., and Feuerstein G.Z. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 23 2-3 (1994) 103-114
134. Laman J.D., Van Meurs M., Schellekens M.M., de Boer M., Melchers B., Massacesi L., et al. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J Neuroimmunol 86 1 (6-1-1998) 30-45
135. Kamm K., Vanderkolk W., Lawrence C., Jonker M., and Davis A.T. The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J Trauma 60 1 (2006) 152-157
136. Vitarbo E.A., Chatzipanteli K., Kinoshita K., Truettner J.S., Alonso O.F., and Dietrich W.D. Tumor necrosis factor alpha expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery 55 2 (2004) 416-424
137. Relton J.K., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29 2 (1992) 243-246
138. Toulmond S., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 2-13- 671 2 (1995) 261-266
139. Martin D., and Near S.L. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J Neuroimmunol 61 2 (1995) 241-245
140. Mrak R.E., and Griffin W.S. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 22 6 (2001) 903-908
141. Selmaj K.W., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23 (1988) 339-346
142. Bitsch A., Kuhlmann T., Da Costa C., Bunkowski S., Polak T., and Bruck W. Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia 29 4 (2000) 366-375
143. Selmaj K., Raine C.S., Cannella B., and Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87 (1991) 949-954
144. Hofman F.M., Hinton D.R., Johnson K., and Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170 2 (1989) 607-612
145. Nawashiro H., Martin D., and Hallenbeck J.M. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17 2 (1997) 229-232
146. Mayne M., Ni W., Yan H.J., Xue M., Johnston J.B., Del Bigio M.R., et al. Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage. Stroke 32 1 (2001) 240-248
147. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci USA 96 15 (1999) 8721-8726
148. Korner H., Lemckert F.A., Chaudhri G., Etteldorf S., and Sedgwick J.D. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur J Immunol 27 8 (1997) 1973-1981
149. Selmaj K.W., and Raine C.S. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45 6 Suppl 6 (1995) S44-S49
150. Kim G.M., Xu J., Xu J., Song S.K., Yan P., Ku G., et al. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J Neurosci 21 17 (2001) 6617-6625
151. Mason J.L., Suzuki K., Chaplin D.D., and Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J Neurosci 21 18 (2001) 7046-7052
152. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 7 (1998) 436-445
153. Ransohoff R.M. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J Leukoc Biol 62 5 (1997) 645-652
154. Glabinski A.R., Tani M., Tuohy V.K., Tuthill R.J., and Ransohoff R.M. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 9 4 (1995) 315-330
155. Ransohoff R.M., Hamilton T.A., Tani M., Stoler M.H., Shick H.E., Major J.A., et al. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP- 1 in experimental autoimmune encephalomyelitis. FASEB J 7 6 (1993) 592-600
156. Ransohoff R.M. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 98 1 (1999) 57-68
157. Simpson J.E., Newcombe J., Cuzner M.L., and Woodroofe M.N. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84 2 (1998) 238-249
158. Glabinski A.R., Balasingam V., Tani M., Kunkel S.L., Strieter R.M., Yong V.W., et al. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol 156 11 (1996) 4363-4368
159. Lee Y.L., Shih K., Bao P., Ghirnikar R.S., and Eng L.F. Cytokine chemokine expression in contused rat spinal cord. Neurochem Int 36 4-5 (2000) 417-425
160. McTigue D.M., Tani M., Krivacic K., Chernosky A., Kelner G.S., Maciejewski D., et al. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res 53 3 (1998) 368-376
161. Ghirnikar R.S., Lee Y.L., and Eng L.F. Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat. J Neurosci Res 64 6 (2001) 582-589
162. Bartholdi D., and Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 9 7 (1997) 1422-1438
163. Glaser J., Gonzalez R., Perreau V.M., Cotman C.W., and Keirstead H.S. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J Neurosci Res 77 5 (9-1-2004) 701-708
164. Beech J.S., Reckless J., Mosedale D.E., Grainger D.J., Williams S.C., and Menon D.K. Neuroprotection in ischemia-reperfusion injury: an anti-inflammatory approach using a novel broad-spectrum chemokine inhibitor. J Cereb Blood Flow Metab 21 6 (2001) 683-689
165. Ishizuka K., Kimura T., Igata-yi R., Katsuragi S., Takamatsu J., and Miyakawa T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51 3 (1997) 135-138
166. Fuentes M.E., Durham S.K., Swerdel M.R., Lewin A.C., Barton D.S., Megill J.R., et al. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155 12 (1995) 5769-5776
167. Tani M., Fuentes M.E., Peterson J.W., Trapp B.D., Durham S.K., Loy J.K., et al. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest 98 2 (1996) 529-539
168. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9 7 (2006) 917-924
169. Chapman G.A., Moores K., Harrison D., Campbell C.A., Stewart B.R., and Strijbos P.J. Fractalkine Cleavage from Neuronal Membranes Represents an Acute Event in the Inflammatory Response to Excitotoxic Brain Damage. J Neurosci (Online) 8-1- 20 15 (2000) RC87
170. Ubogu E.E., Cossoy M.B., and Ransohoff R.M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27 1 (2006) 48-55
171. Archelos J.J., Previtali S.C., and Hartung H.P. The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci 22 1 (1999) 30-38
172. Popovich P.G., Wei P., and Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377 3 (1997) 443-464
173. Liu T., Young P.R., McDonnell P.C., White R.F., Barone F.C., and Feuerstein G.Z. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett 164 1-2 (1993) 125-128
174. Tonai T., Shiba K., Taketani Y., Ohmoto Y., Murata K., Muraguchi M., et al. A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J Neurochem 78 5 (2001) 1064-1072
175. Taoka Y., and Okajima K. Spinal cord injury in the rat. Prog Neurobiol 56 (1998) 341-358
176. Connolly Jr. E.S., Winfree C.J., Springer T.A., Naka Y., Liao H., et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 97 1 (1996) 209-216
177. Zehntner S.P., Brickman C., Bourbonniere L., Remington L., Caruso M., and Owens T. Neutrophils that infiltrate the central nervous system regulate T cell responses. J Immunol 174 8 (2005) 5124-5131
178. McColl S.R., Staykova M.A., Wozniak A., Fordham S., Bruce J., and Willenborg D.O. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol 161 11 (1998) 6421-6426
179. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17 14 (1997) 5395-5396
180. Blight A.R. Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage. Neuroscience 60 1 (1994) 263-273
181. Giulian D., and Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27 (1990) 33-42
182. Popovich P.G., Guan Z., Wei P., Huitinga I., van Rooijen N., and Stokes B.T. Depletion of hematogenous macrophages promotes partial hind-limb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158 (1999) 351-365
183. Schroeter M., Jander S., Huitinga I., Witte O.W., and Stoll G. Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia. Stroke 28 2 (1997) 382-386
184. Huitinga I., van Rooijen N., de Groot C.J., Uitdehaag B.M., and Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172 (1990) 1025-1033
185. Lazarov-Spiegler O., Rapalino O., Agranov G., and Schwartz M. Restricted inflammatory response in the CNS: a key impediment to axonal regeneration. Mol Med Today 4 (1998) 337-342
186. Batchelor P.E., Liberatore G.T., Wong J., Porritt M.J., Frerichs F., Donnan G.A., et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19 5 (1999) 1708-1716
187. Schwartz M., Lazarov-Spiegler O., Rapalino O., Agranov I., Velan G., and Hadani M. Potential repair of rat spinal cord injuries using stimulated homologous macrophages. Neurosurgery 44 5 (1999) 1041-1046
188. Kotter M.R., Setzu A., Sim F.J., van Rooijen N., and Franklin R.J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35 3 (2001) 204-212
189. Popovich P.G., and Hickey W.F. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 60 7 (2001) 676-685
190. Schroeter M., Jander S., Huitinga I., and Stoll G. CD8+ phagocytes in focal ischemia of the rat brain: predominant origin from hematogenous macrophages and targeting to areas of pannecrosis. Acta Neuropathol (Berl) 101 5 (2001) 440-448
191. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.M., and Jones K.J. Exacerbation of facial motoneuron loss after facial nerve transection in severe conbined immunodefiecient (scid) mice. J Neurosci 19 RC7 (1999) 1-5
192. Serpe C.J., Sanders V.M., and Jones K.J. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J Neurosci Res 62 2 (2000) 273-278
193. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T-cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Med 5 1 (1999) 49-55
194. Moalem G., Yoles E., Leibowitz-Amit R., Muller-Gilor S., Mor F., Cohen I.R., et al. Autoimmune T cells retard the loss of function in injured rat optic nerves. J Neuroimmunol 106 1-2 (2000) 189-197
195. Moalem G., Gdalyahu A., Leibowitz-Amit R., Yoles E., Muller-Gilor S., Shani Y., et al. Production of neurotrophins by activated T-cells: implications for neuroprotective autoimmunity. J Autoimmun 15 (2000) 331-345
196. Jones T.B., Ankeny D.P., Guan Z., McGaughy V., Fisher L.C., Basso D.M., et al. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci 24 (2004) 3752-3776